Severe <scp>COVID</scp>‐19 patients show a dysregulation of the <scp>NLRP3</scp> inflammasome in circulating neutrophils
Vinícius Nunes Cordeiro Leal, Milena M. S. Andrade, Franciane Mouradian Emidio Teixeira, Raylane A. G. Cambui, Mariela Estefany Gislene Vera Roa, Leticia Girardi Marra, Suemy M. Yamada, Ricardo Wesley Alberca, Sarah Cristina Gozzi-Silva, Tatiana Mina Yendo, Lucas C. Netto, Alberto J.S. Duarte, Maria Notomi Sato, Alessandra Pontillo
Abstract
SARS-CoV-2 triggers inflammasome-dependent release of pro-inflammatory cytokine IL-1β and pyroptosis, therefore, contributes to the huge inflammatory response observed in severe COVID-19 patients. Less is known about the engagement of inflammasome in neutrophils, main players in tissue injury and severe infection. We studied the activation of the inflammasome in neutrophils from severe COVID-19 patients and assessed its consequence in term of cells contribution to disease pathogenesis. We demonstrated that NLRP3 inflammasome is dramatically activated in neutrophils from severe COVID-19 patients and that the specific inhibition of NLRP3 reverts neutrophils' activation. Next, the stimulation of severe patients' neutrophils with common NLRP3 stimuli was not able to further activate the inflammasome, possibly due to exhaustion or increased percentage of circulating immature neutrophils. Collectively, our results demonstrate that the NLRP3 inflammasome is hyperactivated in severe COVID-19 neutrophils and its exhaustion may be responsible for the increased susceptibility to subsequent (and possibly lethal) infections. Our findings thus include a novel piece in the complex puzzle of COVID-19 pathogenesis.